Associations between pain and cognitive impairment in older adults: findings from the birjand longitudinal aging study Authors: Akam Ramezani, Shakiba Rahimi, Azin Soltani, Hossein Fakhrzadeh, Mitra Moodi, Hanieh-Sadat Ejtahed, Farshad Sharifi Published: 2026 ABSTRACT BackgroundChronic pain is highly prevalent among older adults and has been shown to be associated with differences in cognitive function. While pain intensity reflects the severity of pain, pain interference assesses the extent to which pain disrupts daily activities. Distinguishing between these dimensions of pain and their associations with cognitive function may improve understanding of how pain relates to cognitive health in older populations.MethodsThis cross-sectional study was conducted using baseline data from the Birjand Longitudinal Aging Study (BLAS). Pain was assessed using the Brief Pain Inventory (BPI), with pain severity defined as the mean of items 3–6 and pain interference assessed using item 9. Cognitive impairment was determined based on the combination results of the Six Item Cognitive Impairment Test (6-CIT), the Abbreviated Mental Test Score (AMTS), and the Category Fluency Test (CFT). Multiple logistic regression models were employed to examine associations between pain measures and cognitive impairment, adjusting for potential confounders.ResultsAmong 1,343 participants (mean age: 69.73 ± 7.53 years; 51.82% female), 59.64% were classified as cognitively impaired. In analyses adjusted for covariates selected based on the DAG-informed model, both pain severity and pain interference were significantly associated with cognitive impairment (pain severity: OR = 1.09, 95% CI: 1.02–1.15, p = 0.005; pain interference: OR = 1.13, 95% CI: 1.04–1.22, p = 0.003). Sensitivity analyses showed consistent findings, with significant associations observed for both pain severity (OR = 1.12, 95% CI: 1.03–1.21, p = 0.004) and pain interference (OR = 1.16, 95% CI: 1.05–1.28, p = 0.002).ConclusionBoth pain severity and pain interference were significantly associated with cognitive impairment after adjustment for key confounders. These findings highlight the importance of addressing pain’s impact on daily functioning to mitigate cognitive decline in this population.Supplementary InformationThe online version contains supplementary material available at 10.1007/s40520-026-03419-y. Introduction Cognitive impairment refers to a decline in one or more cognitive functions across various domains, such as executive functioning, memory, attention, numerical skills, language, literacy, and orientation. It is categorized into two main types: mild cognitive impairment and dementia [1]. Approximately 55 million individuals globally are affected by dementia, with a higher concentration in low- and middle-income countries [2]. According to a recent systematic review, the prevalence of dementia in Iran exhibits significant geographical variation, ranging from 0.02% to 0.43% [3]. Also in terms of economic impact, it is estimated that $810,391,868 is expended annually on Alzheimer’s disease [4]. Current medications for Alzheimer’s disease show limited efficacy in altering cognitive decline [5]. As a result, action should be taken to slow disease progression. Low physical activity, hypertension, obesity, and depression are some known risk factors of cognitive impairment [6]. Some studies also have shown the relationship between pain and cognitive decline [7, 8]. The increasing prevalence of both chronic and acute diseases due to aging has increased the likelihood of experiencing pain in older adults [9]. Moreover, in developing countries, people who suffer from pain do not have proper access to treatment [10]. According to the results of two cohort studies, chronic pain measured at the baseline was found to predict memory decline and/or an increased risk of dementia after four [11] or twelve years follow-up [8]. A recent cohort study that assessed both pain intensity in relation to cognitive impairment and pain interference with daily activities, demonstrated that only pain interference was found to increase the risk of cognitive decline [7]. On the other hand, a meta-analysis that included ten longitudinal cohort studies showed that individuals experiencing chronic pain were not at increased risk for developing cognitive impairment [12]. There are several potential pathways in which pain may contribute to cognitive decline. The most common explanation is the competition hypothesis. Pain occupies brain areas that are responsible for cognition [13, 14]. Also, in individuals with chronic pain, the gray matter of cortical regions, including the frontal cortex, has structural changes [15]. In addition, there are some other mechanisms, such as neuroinflammation [16, 17] and existing psychosocial variables including depression and sleep deprivation [6, 18] in painful conditions that mediate cognitive decline. The complex interplay between chronic pain and cognitive decline underscores the need for further investigation. Understanding the association between pain and cognitive function provides critical insights and paves the way for more holistic approaches to treatment. Due to the high burden of cognitive impairment on health systems and poor pain management in developing countries, we aimed to study, the relationship between pain and cognitive impairment in a large community-based sample of older individuals in Iran. Methods Study design and population This study is based on a cross-sectional analysis of the baseline data collected from the Birjand Longitudinal Aging Study (BLAS), which took place from September 2018 to April 2019. The BLAS is an ongoing research project that focuses on individuals aged 60 and older living in both urban and rural areas of Birjand County, located in the eastern part of Iran. For the urban part of the study, researchers identified 70 clusters based on postal codes, selecting 20 individuals from each cluster [19]. In the rural areas, participants were recruited from ten health centers across Birjand County, using both digital and paper-based records. To be included in the study, participants had to be 60 years or older and able to participate actively. Due to the participants’ advanced age, we did not apply any pain-related inclusion criteria. We excluded those who were bedridden, or suffered from conditions like Alzheimer’s disease that made communication difficult, as well as those with a life expectancy of less than six months. For the current study, data from 1343 participants were utilized out of the 1420 individuals from the initial wave of the BLAS cohort. Because this study is a secondary analysis of BLAS data, no separate power calculation was conducted. The sample size was determined by the number of participants with complete data, while the original BLAS cohort had already undergone full sample size and power justification. Data collection process involved eight teams of trained interviewers, each responsible for gathering different types of information. Data were recorded using the Digit software, which helped validate the information in real-time and minimized missing data. All the collected data was securely stored on a remote server at the Endocrinology and Metabolism Research Institute in Tehran. We used detailed, validated questionnaires to collect a wide range of information, including sociodemographic details such as age, gender, education, occupation, marital status, income, smoking habits, physical activity, and health. Participants were also asked about their physical and mental health, pain levels, and any chronic conditions they had, including hypertension, diabetes, heart disease, Alzheimer’s, Parkinson’s, and many others. More information on the study design and methods can be found in previously published study protocol [19]. Cognitive status assessment Cognitive function was assessed using three different evaluation tools. These included the Six Item Cognitive Impairment Test (6-CIT), the Abbreviated Mental Test Score (AMTS), and the Category Fluency Test (CFT), which specifically focused on animal naming. The 6-CIT is a relatively new tool that includes six items designed to assess orientation, memory, and attention. The participants who scored between 0 and 7 were considered to have normal cognitive function, while those scoring 8 or higher were classified as having cognitive impairment, which may indicate dementia [20]. The AMTS, which is available in Persian, consists of 10 questions that evaluate both short-term and long-term memory, as well as orientation and attention. The Persian AMTS demonstrated acceptable internal consistency (Cronbach’s alpha = 0.90). Using a cutoff score of 6 and 7, the tool showed adequate sensitivity (99% and 94%, respectively) and specificity (85% and 86%, respectively) for detecting cognitive impairment [21]. Finally, the Category Fluency Test (CFT), which assesses semantic memory and language abilities, asked participants to name as many animals as possible in 60 s. This test is commonly used to evaluate how well individuals can access stored knowledge and produce words under time constraints [22]. Cognitive impairment had to be indicated across all three validated instruments before a participant could be classified as cognitively impaired. This approach was chosen to minimize false positives, increase accuracy, and ensure that only individuals with consistent evidence of impairment were included in the impaired group. Pain assessment Pain was assessed for all participants using the Brief Pain Inventory (BPI). The association between pain and cognitive performance was examined cross-sectionally across the entire sample. The BPI is a validated 9-item self-reported questionnaire designed to measure pain severity and its interference with daily functioning. In this study, pain intensity was assessed using the mean of BPI items 3 through 6, representing overall pain severity over the past week. Each item is rated on a 10-point Likert scale ranging from 0 (“no pain”) to 10 (“the worst pain imaginable”), with higher scores indicating greater pain severity. Prior studies have reported a correlation between the average pain item and the 4-item BPI severity index [23, 24]. Pain interference was evaluated using the BPI-9 score, comprising seven items that assess the extent to which pain interferes with general activity, walking ability, work, mood, enjoyment of life, social relationships, and sleep. Each item was rated on a 10-point Likert scale from 0 (“does not interfere”) to 10 (“completely interferes”), and a composite pain interference score was calculated as the mean of these items. The psychometric properties of the BPI have been previously validated in the Iranian population and it showed good internal consistency (Cronbach’s alpha ranging from 0.87 to 0.91) [25]. Other variables The Mini Nutritional Assessment (MNA) was employed to assess the nutritional status of the participants. This standardized 18-item questionnaire encompasses various domains, including anthropometric measurements, dietary habits, and global health assessments, with a total possible score of 30. Based on their scores, participants were categorized into three groups: malnourished (score ≤ 16.5), at risk of malnutrition (score between 17 and 23.5), and well-nourished (score > 23.5). The MNA is among the most widely utilized nutritional screening tools for older adults in Iran and has been validated for this population with approximately 82% sensitivity and 63% specificity [26–28]. The Patient Health Questionnaire-9 (PHQ-9) was utilized to assess the presence and severity of depression. As a component of the PRIME-MD diagnostic tool, the PHQ-9 is recommended for the evaluation, screening, and diagnosis of mood disorders, particularly in older adults. This instrument has been validated for use within the Iranian population and revealed good internal consistency (Cronbach’s alpha = 0.88) and acceptable test–retest reliability (0.79) [29, 30]. Additionally, the duration, pattern, and quality of sleep were assessed using seven targeted items derived from the Pittsburgh Sleep Quality Index (PSQI) [31]. Moreover, this study assessed a range of covariates, including socio-demographic characteristics, health behaviors, anthropometric measurements, and health status indicators. Socio-demographic variables included age (years), sex (male or female), educational attainment (illiterate, school, diploma, or university), marital status (married or unmarried/widowed/divorced), living arrangement (living alone or with others), wealth quintile (second to fifth), and employment status (retired/unemployed, housewife, or employed). Health behavior variables included cigarette smoking (yes/no) and physical activity level (inactive/active). Anthropometric measurements included body mass index (BMI), calculated as weight in kilograms divided by height in meters squared (kg/m²). Health status indicators encompassed the presence of underlying chronic diseases and current medication use, as self-reported by participants. Statistical analysis Categorical variables were presented as frequencies and percentages, while continuous variables were summarized using descriptive statistics, including means and standard deviations. A two-sample t-test was applied to examine the relationship between cognitive status and quantitative variables. For categorical variables, either Fisher’s exact test or the chi-square test was used to evaluate group differences. Participants were divided into two groups for the analysis: those classified as cognitively normal based on the results of three cognitive assessments were categorized as having normal cognition, while the remaining participants were categorized as cognitively impaired. In addition, a sensitivity analysis was conducted comparing participants who demonstrated normal performance on all three cognitive tests with those who showed impairment on all three tests, in order to assess the robustness of the findings. Univariate and multivariable binary logistic regression models were used to examine the association between pain scores and cognitive impairment, with pain scores entered as continuous variables. A directed acyclic graph (DAG) was developed using DAGitty to represent assumed causal relationships between pain, cognitive impairment, and potential confounders. Covariates included in the final regression models were selected based on the minimally sufficient adjustment set identified from this DAG [32]. The results were presented as odds ratios (ORs) with 95% confidence intervals (CIs). Data analysis was conducted using STATA version 17.0 (StataCorp LLC, College Station, TX, USA). A p-value of ≤ 0.05 was considered statistically significant. Results The study included 1343 participants, with 696 (51.82%) females and 647 (48.18%) males. The mean age of the participants was 69.73 ± 7.53 years. Most participants were nonsmokers (91.36%) and approximately half were physically active (50.85%). Only 7.89% (n = 106) had attained a university-level education, and the majority were either housekeepers or retired (82.35%). Based on the combined results of the three cognitive assessments, 801 participants (59.64%) were classified as cognitively impaired, while 542 (40.36%) were classified as cognitively normal. As shown in Table 1, cognitive impairment was significantly associated with older age, female sex, lower educational attainment, physical inactivity, living alone, poorer nutritional status, being a housekeeper, and the presence of depressive symptoms (all p < 0.01). In contrast, no significant differences were observed between cognitive status groups with respect to BMI, smoking status, multimorbidity, polypharmacy, or sleep quality. Both pain severity score, and pain interference score were higher in cognitive impaired participants (Pain Severity: 4.13 ± 2.29; Pain Interference: 3.02 ± 2.21), in comparison to participants with normal cognition (Pain Severity: 3.34 ± 2.19; Pain Interference: 2.10 ± 1.57). Table 1Demographic and characteristics of participants according to their cognitive statusVariablesNormal cognitiveImpaired cognitiveP-ValueFreq.PercentFreq.PercentSexfemale21038.7548660.67< 0.01male33261.2531539.33Age60–6936266.7939148.81< 0.0170–7915127.8627033.71≥ 80295.3514017.48Educational levelIlliterate15127.8645556.8< 0.01Primary school17532.2924830.96High school529.59232.87Diploma9317.16404.99Academic7113.1354.37BMILow body weight213.87425.240.069Ideal body weight17933.0330538.08Over weight22741.8828435.46Obese11521.2217021.22Physical activityInactive22140.8543854.68< 0.01Active32059.1536345.32SmokingYes519.41658.110.407No49190.5973691.89Living statusLive with others50893.7367484.14< 0.01Live alone346.2712715.86MNAMalnourished40.74111.37< 0.01At risk10118.6324230.21Well nourished43780.6354868.41Morbidity numberLess than 2 morbidities29657.5941454.550.284≥ 2 morbidities21842.4134545.45Use more than 3 drugsYes7513.8413216.480.188No46786.1666983.52Job statusRetired29053.5121026.22< 0.01Employed7012.9210012.48Housekeeper15328.2345356.55Unemployed295.35384.47PHQ9Depressed mood5410.0421326.59< 0.01No depressed mood48489.9658873.41Sleep qualityVery good499.04526.490.249Relatively good35966.2456270.16Relatively bad12122.3216520.6Vary bad132.4222.75Pain Severity ScoreMean ± SD3.34 ± 2.194.13 ± 2.29< 0.01Pain Interference ScoreMean ± SD2.10 ± 1.553.02 ± 2.21< 0.01 Table 1Demographic and characteristics of participants according to their cognitive statusVariablesNormal cognitiveImpaired cognitiveP-ValueFreq.PercentFreq.PercentSexfemale21038.7548660.67< 0.01male33261.2531539.33Age60–6936266.7939148.81< 0.0170–7915127.8627033.71≥ 80295.3514017.48Educational levelIlliterate15127.8645556.8< 0.01Primary school17532.2924830.96High school529.59232.87Diploma9317.16404.99Academic7113.1354.37BMILow body weight213.87425.240.069Ideal body weight17933.0330538.08Over weight22741.8828435.46Obese11521.2217021.22Physical activityInactive22140.8543854.68< 0.01Active32059.1536345.32SmokingYes519.41658.110.407No49190.5973691.89Living statusLive with others50893.7367484.14< 0.01Live alone346.2712715.86MNAMalnourished40.74111.37< 0.01At risk10118.6324230.21Well nourished43780.6354868.41Morbidity numberLess than 2 morbidities29657.5941454.550.284≥ 2 morbidities21842.4134545.45Use more than 3 drugsYes7513.8413216.480.188No46786.1666983.52Job statusRetired29053.5121026.22< 0.01Employed7012.9210012.48Housekeeper15328.2345356.55Unemployed295.35384.47PHQ9Depressed mood5410.0421326.59< 0.01No depressed mood48489.9658873.41Sleep qualityVery good499.04526.490.249Relatively good35966.2456270.16Relatively bad12122.3216520.6Vary bad132.4222.75Pain Severity ScoreMean ± SD3.34 ± 2.194.13 ± 2.29< 0.01Pain Interference ScoreMean ± SD2.10 ± 1.553.02 ± 2.21< 0.01 Demographic and characteristics of participants according to their cognitive status Associations between pain measures and cognitive impairment are presented in Table 2. In crude analyses, both pain severity score and pain interference score were significantly associated with cognitive impairment (pain severity score: OR = 1.16, 95% CI: 1.11–1.22, p < 0.001; pain interference score: OR = 1.29, 95% CI: 1.21–1.37, p < 0.001). After adjustment for age and sex (Model 1), these associations remained statistically significant (pain severity score: OR = 1.09, 95% CI: 1.03–1.15, p = 0.001; pain interference score: OR = 1.16, 95% CI: 1.08–1.24, p < 0.001). Following further adjustment for the covariates selected based on the DAG-informed model—including age, BMI, MNA, multimorbidity, smoking status, physical activity, sleep quality, and PHQ-9 (Model 2)—both associations remained statistically significant (pain severity score: OR = 1.09, 95% CI: 1.02–1.15, p = 0.005; pain interference score: OR = 1.13, 95% CI: 1.04–1.22, p = 0.003). DAG results are presented in Fig. 1. In the fully adjusted model (Model 3), the association between pain severity score and cognitive impairment was no longer statistically significant (OR = 1.03, 95% CI: 0.96–1.10, p = 0.334), whereas pain interference score remained significantly associated with cognitive impairment (OR = 1.09, 95% CI: 1.00–1.19, p = 0.038). Table 2Association between pain measures and cognitive impairment: Results from logistic regression modelsModelsPain Severity ScorePain Interference ScoreOR (95% CI)p-valueOR (95% CI)p-value Crude 1.16 (1.11–1.22)<0.0011.29 (1.21–1.37)<0.001 Model 1 1.09 (1.03–1.15)0.0011.16 (1.08–1.24)<0.001 Model 2 1.09 (1.02–1.15)0.0051.13 (1.04–1.22)0.003 Model 3 1.03 (0.96–1.10)0.3341.09 (1.00-1.19)0.038Model 1: adjusted for age, sexModel 2: best model according to the DAG results: adjusted for age, BMI, MNA, multimorbidity, smoking, physical activity, sleep quality, PHQ9Model 3: fully-adjusted model: adjusted for sex, age, education year, wealth quintile, living arrangement, BMI, MNA, multimorbidity, polypharmacy, physical activity, current smoking, job, sleep quality, PHQ9 Table 2Association between pain measures and cognitive impairment: Results from logistic regression modelsModelsPain Severity ScorePain Interference ScoreOR (95% CI)p-valueOR (95% CI)p-value Crude 1.16 (1.11–1.22)<0.0011.29 (1.21–1.37)<0.001 Model 1 1.09 (1.03–1.15)0.0011.16 (1.08–1.24)<0.001 Model 2 1.09 (1.02–1.15)0.0051.13 (1.04–1.22)0.003 Model 3 1.03 (0.96–1.10)0.3341.09 (1.00-1.19)0.038Model 1: adjusted for age, sexModel 2: best model according to the DAG results: adjusted for age, BMI, MNA, multimorbidity, smoking, physical activity, sleep quality, PHQ9Model 3: fully-adjusted model: adjusted for sex, age, education year, wealth quintile, living arrangement, BMI, MNA, multimorbidity, polypharmacy, physical activity, current smoking, job, sleep quality, PHQ9 Association between pain measures and cognitive impairment: Results from logistic regression models Model 1: adjusted for age, sex Model 2: best model according to the DAG results: adjusted for age, BMI, MNA, multimorbidity, smoking, physical activity, sleep quality, PHQ9 Model 3: fully-adjusted model: adjusted for sex, age, education year, wealth quintile, living arrangement, BMI, MNA, multimorbidity, polypharmacy, physical activity, current smoking, job, sleep quality, PHQ9 Fig. 1Directed acyclic graph (DAG) representing the relationships between pain, cognitive impairment, and potential confounders Directed acyclic graph (DAG) representing the relationships between pain, cognitive impairment, and potential confounders Sensitivity analyses, including participants with normal performance on all three cognitive tests and those with impairment on all three tests, showed broadly similar patterns to the main analyses (Table 3). Significant associations were observed in crude models (pain severity score: OR = 1.25, 95% CI: 1.17–1.32, p < 0.001; pain interference score: OR = 1.41, 95% CI: 1.30–1.52, p < 0.001), as well as in minimally and DAG-adjusted models (Model 1 and Model 2). However, these associations were attenuated and no longer statistically significant in the fully adjusted model (pain severity score: OR = 1.00, 95% CI: 0.91–1.10, p = 0.971; pain interference score: OR = 1.08, 95% CI: 0.96–1.22, p = 0.154). Table 3Sensitivity analysis of the association between pain measures and cognitive impairmentModelsPain Severity ScorePain Interference ScoreOR (95% CI)p-valueOR (95% CI)p-value Crude 1.25 (1.17–1.32)< 0.0011.41 (1.30–1.52)< 0.001 Model 1 1.12 (1.05–1.21)0.0011.19 (1.09–1.29)< 0.001 Model 2 1.12 (1.03–1.21)0.0041.16 (1.05–1.28)0.002 Model 3 1.00 (0.91–1.10)0.9711.08 (0.96–1.22)0.154Model 1: adjusted for age, sexModel 2: best model according to the DAG results: adjusted for age, BMI, MNA, multimorbidity, smoking, physical activity, sleep quality, PHQ9Model 3: fully-adjusted model: adjusted for sex, age, education year, wealth quintile, living arrangement, BMI, MNA, multimorbidity, polypharmacy, physical activity, current smoking, job, sleep quality, PHQ9 Table 3Sensitivity analysis of the association between pain measures and cognitive impairmentModelsPain Severity ScorePain Interference ScoreOR (95% CI)p-valueOR (95% CI)p-value Crude 1.25 (1.17–1.32)< 0.0011.41 (1.30–1.52)< 0.001 Model 1 1.12 (1.05–1.21)0.0011.19 (1.09–1.29)< 0.001 Model 2 1.12 (1.03–1.21)0.0041.16 (1.05–1.28)0.002 Model 3 1.00 (0.91–1.10)0.9711.08 (0.96–1.22)0.154Model 1: adjusted for age, sexModel 2: best model according to the DAG results: adjusted for age, BMI, MNA, multimorbidity, smoking, physical activity, sleep quality, PHQ9Model 3: fully-adjusted model: adjusted for sex, age, education year, wealth quintile, living arrangement, BMI, MNA, multimorbidity, polypharmacy, physical activity, current smoking, job, sleep quality, PHQ9 Sensitivity analysis of the association between pain measures and cognitive impairment Model 1: adjusted for age, sex Model 2: best model according to the DAG results: adjusted for age, BMI, MNA, multimorbidity, smoking, physical activity, sleep quality, PHQ9 Model 3: fully-adjusted model: adjusted for sex, age, education year, wealth quintile, living arrangement, BMI, MNA, multimorbidity, polypharmacy, physical activity, current smoking, job, sleep quality, PHQ9 Univariate analyses examining associations between socio-demographic and health-related variables and cognitive impairment are presented in Supplementary Table S1. In brief, older age, lower educational attainment, physical inactivity, poorer nutritional status, living alone, and employment as a housekeeper were associated with higher odds of cognitive impairment, whereas higher wealth status and physical activity were associated with lower odds. No significant associations were observed for body mass index, smoking status, multimorbidity, or polypharmacy. Discussion In our study, we found that both pain intensity and pain interference were associated with greater odds of cognitive impairment after adjusting for health and lifestyle factors including BMI, nutritional status, multimorbidity, smoking, physical activity, sleep quality, and depressive symptoms. These findings corroborate previous research showing a positive association between pain interference and cognitive impairment [7, 33–39]. Although the pain measures showed statistically significant associations, the corresponding effect sizes were very small, suggesting that pain contributes only minimally to the overall outcome in practice and may have limited clinical impact despite statistical significance. Prior cross-sectional studies have frequently reported poorer cognitive performance among individuals with chronic pain, particularly in domains such as attention, memory, executive function, and processing speed [33–41]. However, other studies have found no significant associations between pain severity or interference and cognitive dysfunction, highlighting heterogeneity in findings [42, 43]. Longitudinal evidence has also been mixed. While one prospective study showed accelerated 10-year cognitive decline associated with persistent pain [8], and another found a correlation between pain intensity and cognitive decline over 2.75 years [43], two longitudinal studies discovered that, pain interference, but not pain intensity, was linked to the cognitive dysfunction [7, 44]. Long-term cohort studies have further suggested that chronic pain may be associated with accelerated decline in specific cognitive domains, such as processing speed, independent of depression, medication use, and comorbidities [45, 46]. In contrast, some longitudinal analyses have failed to demonstrate a significant association after accounting for confounding factors [47]. Meta-analytic evidence has similarly been inconsistent, with one meta-analysis reporting an overall association between pain and cognitive dysfunction [48], while another focusing on longitudinal cohorts found no clear association between chronic pain and incident cognitive impairment [12]. Several biological and psychological mechanisms may explain the observed association between pain interference and cognitive impairment. Chronic pain involves sustained engagement of central neural networks implicated in both nociception and cognition, although the precise mechanisms remain incompletely understood [49, 50]. Neuroimaging studies have demonstrated that chronic pain is associated with structural and functional alterations in limbic regions, including the hippocampus, amygdala, and cingulate cortex, which play key roles in memory, learning, emotional regulation, and attention [51–53]. Individuals with chronic pain also exhibit a reduction in the volume of the thalamus, insular cortex, and cingulate cortex, which are part of the limbic-related cortex and are involved in executive functions, language, memory, and attention [54, 55]. Apkarian et al. demonstrated prefrontal cortex involvement in chronic pain [56]. This brain region is essential for higher-level cognitive functions including action planning and execution, goal-directed behavior, and inhibitory control [57, 58]. Moreover, alterations in brain structure and connectivity have been linked to maladaptive cognitive processes such as pain catastrophizing, characterized by heightened attention to pain-related stimuli and difficulty disengaging from perceived threats [59–62]. These cognitive-emotional processes may increase cognitive load and limit available cognitive resources, thereby contributing to poorer cognitive performance. Systemic inflammation may represent an additional pathway linking pain and cognitive impairment. Chronic pain has been associated with elevated inflammatory markers, including C-reactive protein (CRP) [46], and inflammation has been implicated in cognitive decline and neurodegenerative processes, including Alzheimer’s disease [63]. Although inflammatory biomarkers were not directly assessed in the present study, this pathway warrants further investigation in future research. The relationship between pain and cognitive function is likely bidirectional. Previous studies have found that higher baseline cognitive performance is associated with lower pain intensity and less interference from pain at follow-up [64, 65]. Previous findings strongly support the significant roles of cognitive and emotional factors in the development of chronic pain [66, 67]. Cognitive dysfunction in individuals with chronic pain has been shown to be more strongly related to psychological distress and negative affect than to pain intensity itself [68, 69]. However, in our study even after adjusting for PHQ-9, pain interference was still associated with cognitive dysfunction. Consistent with prior research, higher levels of depressive symptoms were associated with greater pain interference [70–72]. Furthermore, consistent with the literature suggesting the importance of social engagement for cognitive health, our findings can be considered in light of participants’ living situations. While we did not directly assess the frequency or quality of social interactions, the data on whether individuals lived alone or not may serve as an indirect indicator of social support and engagement. Previous studies have emphasized that social participation, particularly in activities involving social interaction, is vital for stimulating and maintaining cognitive functioning [73, 74]. Therefore, the observed patterns in our cohort could, in part, reflect the impact of differing levels of social connectedness associated with living arrangements, a factor that warrants further investigation with more direct measures of social activity. From a clinical and public health perspective, these findings highlight the importance of assessing pain interference alongside pain intensity, in older adults. Future research should concentrate on the impact of non-pharmacological treatments on the connection between pain and cognitive impairment. By focusing on these strategies, healthcare systems can improve patient outcomes and guide policy decisions on pain management, ultimately enhancing the quality of life for individuals dealing with chronic pain and cognitive decline. This study has several limitations that should be acknowledged. First, the observational nature of the data precludes establishing causal relationships between chronic pain and cognitive decline. Second, reliance on self-reported questionnaires to assess pain may introduce recall bias, particularly among older adults who may have impaired memory. Additionally, the study did not account for specific types of pain (e.g., neuropathic, inflammatory), the duration and chronicity of pain, or the use of pain medications, all of which could influence cognitive outcomes. The absence of these variables limits the granularity of our findings. Further studies should explicitly evaluate the presence and duration of chronic pain to more accurately capture its contribution to cognitive outcomes. In addition, further research should utilize prospective longitudinal studies with well-defined pain classifications and thorough cognitive evaluations, while accounting for potential confounders, to better understand the temporal relationships and causal mechanisms connecting chronic pain to cognitive decline and dementia. Despite these limitations, the study has several important strengths. The large sample size and population-based design of the Birjand Longitudinal Aging Study enhance the statistical power and generalizability of the findings to community-dwelling older adults. Cognitive function was assessed using two validated dementia screening instruments and a measure of phonemic fluency, capturing complementary cognitive domains and aiming to reduce the likelihood of outcome misclassification. In addition, adjustment for a wide range of potential confounders strengthens the robustness of the observed association between pain interference and cognitive impairment. These strengths support the validity of the findings and highlight the importance of distinguishing pain interference from pain intensity in studies of cognitive health in older adults. Future longitudinal studies with detailed pain phenotyping and comprehensive cognitive assessment are warranted to clarify causal pathways linking pain to cognitive decline. Conclusion In this population-based study of older adults, both pain intensity and pain interference showed association with cognitive dysfunction. However, the association was more consistent and robust for pain interference, suggesting that the functional impact of pain on daily life may play a more critical role in cognitive health than pain severity alone. Differentiating pain dimensions may therefore help identify older individuals at higher risk of cognitive impairment. Clinically, routine assessment of pain interference and interventions targeting pain-related functional limitations may represent modifiable strategies to support cognitive health in aging populations. Future longitudinal studies with detailed pain characterization are needed to clarify causal pathways and underlying mechanisms. Supplementary Material Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 1